Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada
Open Access
- 15 October 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (8) , 1139-1142
- https://doi.org/10.1086/378304
Abstract
Although information on efficacy and adverse drug reactions is lacking, ribavirin has been used empirically for the treatment of severe acute respiraKeywords
This publication has 19 references indexed in Scilit:
- Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto AreaJAMA, 2003
- A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong KongNew England Journal of Medicine, 2003
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003
- Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis CAlimentary Pharmacology & Therapeutics, 2002
- Treatment of RSV Pneumonia in Adults — Evidence of Ribavirin Effectiveness?Annals of Pharmacotherapy, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Severe Measles Pneumonitis in Adults: Evaluation of Clinical Characteristics and Therapy with Intravenous RibavirinClinical Infectious Diseases, 1994
- Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal SyndromeThe Journal of Infectious Diseases, 1991
- Lassa FeverNew England Journal of Medicine, 1986
- Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideScience, 1972